rethinkPeptides Search
Menu
Study breakdown

Lactoferrin-Derived Peptides Kill Leukemia Cells by Triggering Programmed Cell Death

In VitroPreliminary evidence
The takeaway

Peptides from bovine lactoferrin's N-terminal region induced apoptosis (programmed cell death) in human leukemia HL-60 cells, with lactoferricin being the most potent anti-leukemic fragment.

Apoptosis triggered

Lactoferricin killed leukemia cells through programmed cell death — a clean cancer-killing mechanism that spares surrounding tissue

What the researchers found

Bovine lactoferricin induced apoptosis in human HL-60 leukemia cells more potently than intact lactoferrin, with activity dependent on native protein structure, demonstrating structure-specific anti-leukemic killing.

Why it matters

Leukemia needs new treatments, especially for resistant cases. A milk-derived peptide that triggers cancer cell suicide through apoptosis offers a natural, potentially less toxic approach to blood cancer therapy.

How the study worked

In-vitro study exposing human HL-60 myeloid leukemia cells to lactoferrin, lactoferricin, and modified forms. Cell viability, apoptosis markers, and structure-activity relationships assessed.

What this study cannot tell us

Single leukemia cell line (HL-60). In-vitro apoptosis doesn't guarantee in-vivo anti-leukemic efficacy. Therapeutic concentrations may differ from achievable blood levels.

How to read the evidence

Preliminary in-vitro evidence with clear apoptosis induction and structure-activity data in a standard leukemia cell line.

When this study was published

Published in 2002. Lactoferricin's anticancer properties have been further characterized across multiple cancer types.

The bigger picture

Natural food-derived peptides with anticancer activity represent a convergence of nutrition and oncology. Lactoferricin's ability to trigger leukemia cell apoptosis opens natural product-based cancer therapy.

Questions still open

  • Can lactoferricin reach therapeutic concentrations in leukemia patients?
  • Does it kill primary leukemia cells, not just cell lines?
  • Could oral lactoferrin supplementation contribute to leukemia prevention?

Common questions

Can milk peptides fight blood cancer?
In lab tests, lactoferricin (a peptide from milk protein) triggered leukemia cell death through apoptosis — the body's natural cell death program. This makes it a potential natural anticancer compound.
Does drinking milk help prevent leukemia?
We can't conclude that from this study. The concentrations used in the lab may be much higher than what milk consumption would produce. However, lactoferrin's anticancer properties support its investigation as a supplement.

Read the original research

Peptides from the N-terminal end of bovine lactoferrin induce apoptosis in human leukemic (HL-60) cells.

Journal of dairy science, 85(9), 2065-74

Citation

Roy, M K; Kuwabara, Y; Hara, K; Watanabe, Y; Tamai, Y. (2002). Peptides from the N-terminal end of bovine lactoferrin induce apoptosis in human leukemic (HL-60) cells.. Journal of dairy science, 85(9), 2065-74.